ARCHIVES

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

This article is from The Cancer Letter archive.

Vol. 06 No. 30 | July 25, 1980

Download PDF Visit The Full Archive

Related Articles

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

ECOG, ACRIN Form Single Cooperative Group

May 18, 2012

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006